Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ad5-ncov (1 trial)
Azoximer (2 trials)
inactivated influenza vaccine (1 trial)
chondroitin (1 trial)
collagen (1 trial)
glucosamine (1 trial)
Coronavirus Infections (Phase 3)
Influenza, Human (Phase 3)
Respiratory Tract Infections (Phase 3)
Trials (6 total)
Trial APIs (6 total)